An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses
- 583 Downloads
MD2, a 160-residue accessory glycoprotein, is responsible for the recognition and binding of Gram-negative bacterial membrane component, lipopolysaccharide (LPS). Internalization of pathogen inside the mononuclear phagocytes has also been attributed to MD2 which leads to the clearance of pathogens from the host. However, not much is known about the segments in MD2 that are responsible for LPS interaction or internalization of pathogen inside the defense cells. A 16-residue stretch (MD54) from MD2 protein has been identified that possesses a short heptad repeat sequence and four cationic residues enabling it to participate in both hydrophobic and electrostatic interactions with LPS. An MD54 analog of the same size was also designed in which a leucine residue at a heptadic position was replaced with an alanine residue. MD54 but not its analog, MMD54 induced aggregation of LPS and aided in its internalization within THP-1 monocytes. Furthermore, MD54 inhibited LPS-induced nuclear translocation of NF-κB in PMA-treated THP-1 and TLR4/MD2/CD14-transfected HEK-293T cells and the production of pro-inflammatory cytokines. In addition, in in vivo experiments, MD54 showed marked protection and survival of mice against LPS-induced inflammation and death. Overall, we have identified a short peptide with heptad repeat sequence from MD2 that can cause aggregation of LPS and abet in its internalization within THP-1 cells, resulting in attenuation of LPS-induced pro-inflammatory responses in vitro and in vivo.
KeywordsMD2 Lipopolysaccharide (LPS) aggregation Sepsis Attenuation of LPS-induced pro-inflammatory responses Heptad repeat Synthetic peptides
Cluster of differentiation 14
Human embryonic kidney cells 293
Lymphocyte antigen 96
Nuclear factor kappa-light-chain-enhancer of activated B cells
Pathogen-associated molecular pattern
Pattern recognition receptor
Toll-like receptor 4
Proliferating cell nuclear antigen
Intensive Care Unit
The CSIR-CDRI communication number for this article is 9609. This work was supported by a Council of Scientific and Industrial Research (CSIR) network project BioDiscovery (BSC0120). We are thankful to Dr. Douglous Golenbock (Medicine Department, University of Massachusetts Medical School, Worcester MA) and Dr. Anila Dwivedi (Endocrinology div. CSIR-CDRI, Lucknow.) for providing us with the plasmid constructs. The authors are extremely thankful to Prof. Surajit Bhattacharjya, School of Biological Sciences, Nanyang Technological University, Singapore for editing the revised version of the manuscript. The authors thankfully acknowledge the anonymous reviewers for their constructive criticism and comments in improving the quality of the manuscript. Garima Pant of Sophisticated Analytical Instrumentation Facility (SAIF) and Rima Roy from Molecular and Structural Biology Division, CSIR-CDRI are acknowledged for assistance in using the Confocal Microscope. A. L. Vishwakarma and R. K Purshottam from SAIF and CSIR-CDRI are acknowledged for assistance in using FACS and HPLC facility, respectively. We are thankful to Pharmaceutics Department for providing us the Zeta sizer instrument accessibility. We also thankfully acknowledge National Laboratory Animal Centre, CSIR-Central Drug Research Institute, Lucknow, India for providing us the animals.
JKG and AT conceived the idea and designed the experiments. AT did the major part of the experiments. MKH and NI helped in western and in vivo experiments. AKT and SS assisted us in the peptide synthesis and biophysical experiments, respectively. JKG and AT analyzed the results and wrote the manuscript. All the authors were consulted on the final version of the manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare no competing financial interest.
- 16.Wang Y, Shan X, Chen G, Jiang L, Wang Z, Fang Q, Liu X, Wang J, Zhang Y, Wu W, Liang G (2015) MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis. Br J Pharmacol 172(17):4391–4405. https://doi.org/10.1111/bph.13221 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Srivastava RM, Srivastava S, Singh M, Bajpai VK, Ghosh JK (2012) Consequences of alteration in leucine zipper sequence of melittin in its neutralization of lipopolysaccharide-induced proinflammatory response in macrophage cells and interaction with lipopolysaccharide. J Biol Chem 287(3):1980–1995. https://doi.org/10.1074/jbc.M111.302893 CrossRefPubMedGoogle Scholar
- 21.Yan H, Gu CG, Xu FL, Wu XH, Yin HH, Hu CX, Zhu XD, Liu F, Ge HJ, Chen LY, Zhang XY, Wang ZG, Xing Z, Li L (2013) Identification of synthetic peptides that inhibit lipopolysaccharide (LPS) binding to myeloid differentiation protein-2 (MD-2). J Immunother 36(3):197–207. https://doi.org/10.1097/cji.0b013e31828eed62 CrossRefPubMedGoogle Scholar
- 27.Ahmad A, Yadav SP, Asthana N, Mitra K, Srivastava SP, Ghosh JK (2006) Utilization of an amphipathic leucine zipper sequence to design antibacterial peptides with simultaneous modulation of toxic activity against human red blood cells. J Biol Chem 281(31):22029–22038. https://doi.org/10.1074/jbc.M602378200 CrossRefPubMedGoogle Scholar
- 28.Asthana N, Yadav SP, Ghosh JK (2004) Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity. J Biol Chem 279(53):55042–55050. https://doi.org/10.1074/jbc.M408881200 CrossRefPubMedGoogle Scholar
- 29.Ghosh JK, Ovadia M, Shai Y (1997) A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Biochemistry 36(49):15451–15462. https://doi.org/10.1021/bi971152i CrossRefPubMedGoogle Scholar
- 31.Yadav SP, Kundu B, Ghosh JK (2003) Identification and characterization of an amphipathic leucine zipper-like motif in Escherichia coli toxin hemolysin E. Plausible role in the assembly and membrane destabilization. J Biol Chem 278(51):51023–51034. https://doi.org/10.1074/jbc.M310052200 CrossRefPubMedGoogle Scholar
- 32.Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock RE (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176(4):2455–2464CrossRefPubMedGoogle Scholar
- 39.Liu H, Xu R, Feng L, Guo W, Cao N, Qian C, Teng P, Wang L, Wu X, Sun Y, Li J, Shen Y, Xu Q (2012) A novel chromone derivative with anti-inflammatory property via inhibition of ROS-dependent activation of TRAF6–ASK1–p38 pathway. PLoS One 7(8):e37168. https://doi.org/10.1371/journal.pone.0037168 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Fermino ML, Polli CD, Toledo KA, Liu FT, Hsu DK, Roque-Barreira MC, Pereira-da-Silva G, Bernardes ES, Halbwachs-Mecarelli L (2011) LPS-induced galectin-3 oligomerization results in enhancement of neutrophil activation. PLoS One 6(10):e26004. https://doi.org/10.1371/journal.pone.0026004 CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Kaconis Y, Kowalski I, Howe J, Brauser A, Richter W, Razquin-Olazaran I, Inigo-Pestana M, Garidel P, Rossle M, Martinez de Tejada G, Gutsmann T, Brandenburg K (2011) Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys J 100(11):2652–2661. https://doi.org/10.1016/j.bpj.2011.04.041 CrossRefPubMedPubMedCentralGoogle Scholar